国际眼科杂志
國際眼科雜誌
국제안과잡지
International Eye Science
2015年
11期
1920-1922
,共3页
Toric人工晶状体%白内障%角膜散光
Toric人工晶狀體%白內障%角膜散光
Toric인공정상체%백내장%각막산광
Toric intraocular lens%cataract%corneal astigmatism
目的：：探讨Toric人工晶状体植入治疗白内障合并角膜散光的临床疗效。方法：选择2013-06/2014-07在我院进行超声乳化白内障吸出及人工晶状体植入术合并角膜散光的白内障患者38例46眼作为研究对象,其中20例24眼患者植入Toric人工晶状体,18例22眼患者植入Acrysof IQ人工晶状体,对两组患者的临床疗效进行分析。结果：两组患者术后裸眼视力进行比较,差异有统计学意义(F=5.783,P<0.05)；观察组患者术后1wk,1、3mo裸眼视力明显高于术前,其差异均有统计学意义(P<0.05)；观察组患者术后裸眼视力明显高于对照组,其差异有统计学意义(t=5.248,2.573,2.782；P 均<0.05)。两组患者术后散光情况进行比较,差异有统计学意义( F=5.482,P<0.05)；观察组患者术后1wk,1、3mo的散光改善情况明显优于手术前,其差异有统计学意义(P<0.05)；观察组患者术后散光改善情况明显优于对照组,其差异有统计学意义(t=6.591、3.287、2.167,P均<0.05)。远视力研究中植入Toric人工晶状体有75%的患者不需要配戴眼镜。结论：Toric人工晶状体植入治疗白内障合并角膜散光具有良好的矫正作用,且能明显提高患者术后视觉治疗,有良好的预测性,因此值得在临床推广应用。
目的：：探討Toric人工晶狀體植入治療白內障閤併角膜散光的臨床療效。方法：選擇2013-06/2014-07在我院進行超聲乳化白內障吸齣及人工晶狀體植入術閤併角膜散光的白內障患者38例46眼作為研究對象,其中20例24眼患者植入Toric人工晶狀體,18例22眼患者植入Acrysof IQ人工晶狀體,對兩組患者的臨床療效進行分析。結果：兩組患者術後裸眼視力進行比較,差異有統計學意義(F=5.783,P<0.05)；觀察組患者術後1wk,1、3mo裸眼視力明顯高于術前,其差異均有統計學意義(P<0.05)；觀察組患者術後裸眼視力明顯高于對照組,其差異有統計學意義(t=5.248,2.573,2.782；P 均<0.05)。兩組患者術後散光情況進行比較,差異有統計學意義( F=5.482,P<0.05)；觀察組患者術後1wk,1、3mo的散光改善情況明顯優于手術前,其差異有統計學意義(P<0.05)；觀察組患者術後散光改善情況明顯優于對照組,其差異有統計學意義(t=6.591、3.287、2.167,P均<0.05)。遠視力研究中植入Toric人工晶狀體有75%的患者不需要配戴眼鏡。結論：Toric人工晶狀體植入治療白內障閤併角膜散光具有良好的矯正作用,且能明顯提高患者術後視覺治療,有良好的預測性,因此值得在臨床推廣應用。
목적：：탐토Toric인공정상체식입치료백내장합병각막산광적림상료효。방법：선택2013-06/2014-07재아원진행초성유화백내장흡출급인공정상체식입술합병각막산광적백내장환자38례46안작위연구대상,기중20례24안환자식입Toric인공정상체,18례22안환자식입Acrysof IQ인공정상체,대량조환자적림상료효진행분석。결과：량조환자술후라안시력진행비교,차이유통계학의의(F=5.783,P<0.05)；관찰조환자술후1wk,1、3mo라안시력명현고우술전,기차이균유통계학의의(P<0.05)；관찰조환자술후라안시력명현고우대조조,기차이유통계학의의(t=5.248,2.573,2.782；P 균<0.05)。량조환자술후산광정황진행비교,차이유통계학의의( F=5.482,P<0.05)；관찰조환자술후1wk,1、3mo적산광개선정황명현우우수술전,기차이유통계학의의(P<0.05)；관찰조환자술후산광개선정황명현우우대조조,기차이유통계학의의(t=6.591、3.287、2.167,P균<0.05)。원시력연구중식입Toric인공정상체유75%적환자불수요배대안경。결론：Toric인공정상체식입치료백내장합병각막산광구유량호적교정작용,차능명현제고환자술후시각치료,유량호적예측성,인차치득재림상추엄응용。
? AlM: To investigate the clinical efficacy of Toric intraocular lens ( lOL ) implantation for cataract patients with corneal astigmatism.?METHODS:Thirty-eight patients (46 eyes) with corneal astigmatism undergone phacoemulsification and lOL implantation in our hospital from June 2013 to July 2014 were observed. Twenty cases ( 24 eyes ) received Toric lOL, 18 cases (22 eyes) got Acrysof lQ lOL. The clinical efficacy of the two groups was analyzed.?RESULTS:The difference on visual acuity after surgery between the two groups was statistically significant ( F=5. 783, P<0. 05). The uncorrected visual activity of the observed group after 1wk, 1 and 3mo was significantly higher than that before the operation, the difference was statistically significant ( P<0. 05 );The uncorrected visual activity of the observed group was significantly higher than that in the control group, the difference was statistically significant ( t = 5. 248, 2. 573, 2. 782;all P<0. 05). The difference on the degree of astigmatism after surgery between the two groups was statistically significant (F=5. 482, P<0. 05). At 1wk, 1 and 3mo after the operation treatment, the degree of astigmatism in the observed group was lower than that before operation, the difference was statistically significant ( P < 0. 05 ); The degree of astigmatism in the observed group was lower than that in the control group, the difference was statistically significant ( t = 6. 591, 3. 287, 2. 167;all P<0. 05). The results of distance vision study suggested that 75% patients with lOL implantation do not need to wear spectacles.? CONCLUSlON: Phacoemulsification associated with Toric lOL implantation has good correction effect and prediction for cataract and corneal astigmatism patients, and can improve the visual activity significantly, so it is worthy of clinical application.
